Laus
Gerhard Laus, Innsbruck AT
Patent application number | Description | Published |
---|---|---|
20110306764 | CRYSTALLINE FORM OF AN ORGANIC COMPOUND - The present invention is directed to a crystalline form of 2-[6-[3(R)-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-ylmethyl]-benzonitrile, a process for the preparation of said crystalline form and the use thereof in the manufacture of a pharmaceutical composition. | 12-15-2011 |
Marc Christiaan Laus, Haren NL
Patent application number | Description | Published |
---|---|---|
20150183840 | POTATO PROTEIN ISOLATES - The present invention relates to a process for obtaining a potato protein fraction using a specific absorbent. Specifically, the invention relates to the carrier material, which comprises a specific polymeric material, functionalised with suitable ligands. By the use of a functionalised support carrier according to the present invention, a potato protein fraction can be obtained with higher effectiveness. | 07-02-2015 |
Marc Christiaan Laus, Groningen NL
Patent application number | Description | Published |
---|---|---|
20100036090 | GLYCOALKALOID REMOVAL - The invention relates to a process for the removal of glycoalkaloids, in particular from process streams such as those encountered during isolation of proteins from potatoes. | 02-11-2010 |
20100040591 | NATIVE POTATO PROTEIN ISOLATES - The invention relates to a process for native potato protein isolation, to native potato protein isolates, to the use thereof, and to a food product comprising a native potato protein isolate. The invention provides a novel isolation process for obtaining highly pure native potato protein isolates having a glycoalkaloid concentration of less than 150 ppm. | 02-18-2010 |
20130281669 | NATIVE POTATO PROTEIN ISOLATES - The invention relates to a process for native potato protein isolation, to native potato protein isolates, to the use thereof, and to a food product comprising a native potato protein isolate. | 10-24-2013 |
Michele Laus, Alessandria IT
Patent application number | Description | Published |
---|---|---|
20080275162 | Ptfe-Based Compositions - The invention relates to core-shell particles, said particles comprising: | 11-06-2008 |
20110040039 | TETRAFLUOROETHYLENE POLYMER PARTICLES - Core-shell particles having a core of at least one tetrafluoroethylene (TFE) polymer and having an average primary particle size of less than 50 nm; and a shell of at least one acrylic polymer having recurring units, more than 50% by moles of which being derived from at least one ethylenically unsaturated monomer having directly bonded to one of the sp | 02-17-2011 |
Norbert Laus, Simmelsdorf DE
Patent application number | Description | Published |
---|---|---|
20140218053 | Plastic Film and Touch Sensor - Disclosed is a plastic film and a touch module produced therefrom. The module is constructed from two conductive layers with an insulation layer in between, as are used in capacitive touch pads and/or touch screens, for example. The problem of connecting the respective x or y sensors across two planes in a cost-effective manner employs foldable sensor planes in the plastic film suitable for mass production. The connections and conductor tracks are concentrated on one plane on a sensor side wherein the sensor planes are arranged on flexible materials. The registering of the two planes relative to each other is simplified via a secure mechanical connection of the two planes via a fold in the film. | 08-07-2014 |
Norbert Laus, Furth-Burgfarrnbach DE
Patent application number | Description | Published |
---|---|---|
20110003166 | Method for Producing a Film Element - The invention concerns a process for producing a film element having mutually registered metallic layers ( | 01-06-2011 |
20140205852 | Method for Producing a Film Element - The invention concerns a process for producing a film element having mutually registered metallic layers ( | 07-24-2014 |
Oliver Laus, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20100216964 | METHOD FOR PRODUCING ARYL-ARYL COUPLED COMPOUNDS - The invention relates to a method for producing aryl-aryl coupled compounds. The method is continuous, at least two non-miscible phases (M | 08-26-2010 |
Reiner Laus, Bellevue, WA US
Patent application number | Description | Published |
---|---|---|
20100034842 | Compositions Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease - Provided are alternative reading frame (ARF) polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions that comprise ARF polypeptides. ARF polypeptides and ARF polypeptide-based compositions are useful in the treatment of cancer and infectious disease. | 02-11-2010 |
20120094977 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION - Provided are small-molecule Trp-p8 modulators, including Trp-p8 agonists and Trp-p8 antagonists, and compositions comprising small-molecule Trp-p8 agonists as well as methods for identifying and characterizing novel small-molecule Trp-p8 modulators and methods for decreasing viability and/or inhibiting growth of Trp-p8 expressing cells, methods for activating Trp-p8-mediated cation influx, methods for stimulating apoptosis and/or necrosis, and related methods for the treatment of diseases, including cancers such as lung, breast, colon, and/or prostate cancers as well as other diseases, such as benign prostatic hyperplasia, that are associated with Trp-p8 expression. | 04-19-2012 |
20130190296 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION - Provided are small-molecule Trp-p8 modulators, including Trp-p8 agonists and Tip-p8 antagonists, and compositions comprising small-molecule Trp-p8 agonists as well as methods for identifying and characterizing novel small-molecule Trp-p8 modulators and methods for decreasing viability and/or inhibiting growth of Trp-p8 expressing cells, methods for activating Trp-p8-mediated cation influx, methods for stimulating apoptosis and/or necrosis, and related methods for the treatment of diseases, including cancers such as lung, breast, colon, and/or prostate cancers as well as other diseases, such as benign prostatic hyperplasia, that are associated with Trp-p8 expression. | 07-25-2013 |
Reiner Laus, Saratoga, CA US
Patent application number | Description | Published |
---|---|---|
20080213302 | Methods for treating cancer with MVA - The invention relates to compositions, kits, and methods for cancer therapy using recombinant MVA viruses encoding a tumor-associated antigen, such as HER-2, particularly in combination with taxanes. The taxanes can be administered prior to, at the same time as, or after the recombinant MVA virus. | 09-04-2008 |
20090104225 | USE OF MVA TO TREAT PROSTATE CANCER - The invention relates to compositions, kits, and methods for cancer prophylaxis and therapy using recombinant MVA viruses encoding tumor-associated antigens, such as PSA and PAP. The recombinant MVA viruses can induce B- and T-cell responses. The recombinant MVA viruses can be administered prior to, at the same time as, or after a taxane. | 04-23-2009 |
20110008294 | METHODS FOR TREATING CANCER WITH MVA - The invention relates to compositions, kits, and methods for cancer therapy using recombinant MVA viruses encoding a tumor-associated antigen, such as HER-2, particularly in combination with taxanes. The taxanes can be administered prior to, at the same time as, or after the recombinant MVA virus. | 01-13-2011 |
20110008386 | USE OF MVA TO TREAT PROSTATE CANCER - The invention relates to compositions, kits, and methods for cancer prophylaxis and therapy using recombinant MVA viruses encoding tumor-associated antigens, such as PSA and PAP. The recombinant MVA viruses can induce B- and T-cell responses. The recombinant MVA viruses can be administered prior to, at the same time as, or after a taxane. | 01-13-2011 |